The Alberta Cancer Foundation has committed to raising $10 million over the next five years to bring innovation to Albertans faster, and thanks to your support, they get closer to their goal every day. Only by coming together can we reach that objective and make a difference not only in Alberta but to the world around us. If you didn’t have the chance to get an Epic Ride, Epic Match fundraising gift, we still have a great flash challenge coming your way!

Click here to find out more about where your donations go.

Since 2009, The Enbridge Ride to Conquer Cancer Presented by Evraz has raised over $66 million for the Alberta Cancer Foundation. The Ride to Conquer Cancer series is Canada’s largest peer-to-peer fundraising event.

Funds raised through The Enbridge Ride to Conquer Cancer enable the Alberta Cancer Foundation to support breakthrough cancer research, clinical trials, enhanced care and the discovery of new cancer therapies at the Tom Baker Cancer Centre, Cross Cancer Institute and 15 other centres across Alberta.

As the largest cancer foundation in Alberta, The Alberta Cancer Foundation’s vision is to achieve a cancer-free future by investing in cancer prevention and screening, enhanced care and research across Alberta.

Funds raised through The Enbridge Ride to Conquer Cancer are powering research, clinical trials and enhanced care programs. To find out more about how your dollars are having an impact, continue reading and check out the below infographic.

The Alberta Cancer Foundation supports every single clinical trial that takes place in Alberta, and over the past five years, The Enbridge Ride to Conquer Cancer has given 6,000 Albertans the opportunity to take part in ground-breaking research. Alberta is a national leader in clinical trials and funds raised through The Ride, enabling patients access to promising new cancer treatments, drugs and therapies. In the last year, 927 people signed up for a clinical trial in Alberta—a six per cent increase from the previous year.

Trials underway examine the efficiency of hormone therapy, chemotherapy, radiation therapy and immunotherapy, combinations of treatments, and exploring new, less invasive methods of surgery.

• Brain Cancer Research: Glioblastoma is the most common and deadly form of brain cancer among adults. The progression and complexity of the tumours are often difficult to treat and the median survival for patients is 15 months with less than five per cent of patients surviving beyond five years.
  Researchers in Calgary are currently leading an $8.2-million drug discovery project. Thanks in part to funds from The Enbridge Ride to Conquer Cancer, we are working to identify new drug discoveries that have a chance to make a difference for glioblastoma patients in Alberta and around the world.
• Breast Cancer Research: Every day, 6 Albertans are diagnosed with breast cancer. Funds from The Ride will support ground-breaking research looking to identify biomarkers that could help medical teams determine the best treatment for each patient at the right time.
• Colorectal cancer research: In 2017, nearly 2,500 Albertans will be diagnosed with colorectal cancer. Current treatments work well, but we still lose too many people to this disease and can do better. Funds from The Ride will support a research program that will develop new drugs to block the ability of tumours to resist radiation and chemotherapy by repairing their DNA. Nanocarriers will deliver drugs to tumour tissues where they can increase the potency of the treatment but spare healthy tissue, improving treatment success and quality of life.
• Patient Navigator Program: There are 15 Alberta Cancer Foundation Patient Navigators in rural communities across the province to guide patients through the health system. The navigators support patients and families through the complex cancer journey and understand additional challenges rural Albertans face with a cancer diagnosis. Because of support from the Enbridge Ride to Conquer Cancer, Alberta Cancer Foundation Patient Navigators supported almost 5,000 patients in rural Alberta last year with 17,000 recorded visits to discuss a myriad of cancer-related issues, resulting in a reduction of emergency room and physician visits across the province.
• Prostate Cancer Research: In Alberta, one in seven men will be diagnosed with prostate cancer in their lifetime. If detected early, prostate cancer is one of the most successfully treated cancers. Funds from the Ride will assist Dr. John Lewis to research a biomarker that accurately predicts whether prostate cancer patients are at risk of metastasis and ultimately will assist in developing the best treatment plan for each patient.
• Ovarian Cancer Detection: The Enbridge Ride to Conquer Cancer will help a team of scientists who are challenging ovarian cancer and looking to identify ways to detect cancerous cells earlier. Currently, Dr. Postovit is working to create a test women can do at their regular check- ups showing a marker that helps predict if an ovarian cancer is there. Not only will this test improve patient outcomes but also will provide patients with what matters most: more moments with their loves ones.
• Head and Neck Cancer Therapies: Swallowing disorders affect 70 per cent of patients with head and neck cancer, which can lead to a dependence on tube feeding, affecting social interactions and overall quality of life. The current therapy required is time and labour intensive for both patient and therapist. A research team in Edmonton is testing a mobile app that will receive information from a simple adhesive pad under patients’ chins and instantly share that feedback with clinicians. This will enhance patient quality of life, as they can receive treatment from the comfort of their home. The goal is to have this device in clinical trials within two years.
• Lung Cancer Screening Program: This year alone, nearly 2,000 Albertans are expected to be diagnosed with lung cancer. Sadly, 1,700 will die. So far, no Canadian province has a lung cancer screening program. With help from The Ride, Alberta hopes to be the first, launching a province-wide screening program that best determines who to screen and when, saving many Albertans’ lives.

No matter where a patient faces a cancer diagnosis in this province, we want to ensure they receive the best possible treatment and care. Alberta Cancer Foundation donors and funds from The Ride enable local support at the Tom Baker Cancer Centre in Calgary, the Cross Cancer Institute in Edmonton and 15 other cancer centres around the province. These investments offer patients and families enhanced care over and above what is typically provided and may include comfortable reclining chemo chairs, vital sign machines in clinic rooms, patient journals, blanket warmers during radiation treatment or advanced training for staff that helps improve patient care and quality. Programs include:

• Alberta Cancer Foundation Patient Navigators – There are 15 Alberta Cancer Foundation Patient Navigators in rural communities across the province who assist patients who are struggling with the emotional, financial and physical components of their diagnosis. They explain how treatment will work and understand additional challenges rural Albertans face with a cancer diagnosis. Since the program began, Alberta Cancer Foundation Patient Navigators supported almost 5,000 patients in rural Alberta last year, with 17,000 recorded visits to discuss a myriad of cancer-related issues, resulting in a reduction of emergency room and physician visits across the province.
• Patient Financial Assistance Program – Cancer can be a huge strain on the finances. The costs can be so overwhelming that some patients will decide not to have life-saving therapy to save costs. The Ride will ensure the Alberta Cancer Foundation can continue to provide financial support to patients in need, easing their cancer journey. The Alberta Cancer Foundation Patient Financial Assistance Program covers costs such as housing, medication, transportation and childcare. In the last year, the need for this program in Alberta has almost doubled.
• Patient Comfort – The Ride to Conquer Cancer will enable the Alberta Cancer Foundation to improve patient and family comfort by adding blanket warmers, privacy curtains, reclining treatment chairs and TVs in waiting rooms.

About Us

Net proceeds from The Enbridge^® Ride to Conquer Cancer^® Presented by Evraz will benefit the Alberta Cancer Foundation, the registered charity dedicated to supporting cancer research and programs at the Tom Baker Cancer Centre, the Cross Cancer Institute and 15 other cancer centres across Alberta. We see every day how patients and families benefit from the work that more than 200,000 Alberta Cancer Foundation donors make possible each year. The Foundation provides funding for basic, translational and clinical research, advanced treatment programs, prevention and screening initiatives, equipment and facility enhancements, a patient financial assistance program and psychosocial initiatives at all Alberta cancer centres.

To learn more about the Alberta Cancer Foundation, visit www.albertacancer.ca/

DEDICATED TEAMS

Patients and families across the province count on having access to the most effective programs and best-equipped facilities in Canada, if not the world. Alberta’s team of cancer nurses, radiation therapists, technicians, pharmacists, researchers and doctors are dedicated to giving them the best care available. Research integrated with cancer treatment gives us more information about cancer and provides direct benefits to our patients.

Research also helps us attract and keep the best-trained people for cancer care and training of the next generation of specialists. And equipped with cutting-edge technology and state-of-the-art tools, Alberta physicians and researchers are helping to revolutionize the delivery of cancer treatment.

THE TOM BAKER CANCER CENTRE & THE CROSS CANCER INSTITUTE

The Tom Baker Cancer Centre in Calgary and the Cross Cancer Institute in Edmonton are leading centres of cancer treatment as well as scientific and clinical research to develop new cancer therapies. Albertans are able to access leading treatments three to seven years in advance of those treatments becoming available on a large-scale basis.